Mineralys Therapeutics (MLYS) Institutional Ownership

$26.89 -2.51 (-8.54%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$26.80 -0.09 (-0.34%)

As of 05:59 AM Eastern

Compare

Current Institutional Ownership Percentage: 84.46%
Number of Institutional Buyers (last 12 months): 141
Total Institutional Inflows (last 12 months): $1.34B

Number of Institutional Sellers (last 12 months): 57
Total Institutional Outflows (last 12 months): $561.66M

Get MLYS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Mineralys Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MLYS Institutional Buying and Selling by Quarter

Mineralys Therapeutics Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/9/2026	BlueCrest Capital Management Ltd	85,157	$2.30M	0.1%	N/A	0.096%
9/9/2026	WINTON GROUP Ltd	33,800	$912K	0.0%	N/A	0.038%
9/9/2026	Squarepoint Ops LLC	86,327	$2.33M	0.0%	-18.2%	0.098%
9/8/2026	Arizona State Retirement System	15,357	$414K	0.0%	+22.4%	0.017%
8/25/2026	VIRGINIA RETIREMENT SYSTEMS ET Al	12,350	$333K	0.0%	N/A	0.014%
8/23/2026	Greenland Capital Management LP	30,000	$809K	0.1%	-64.1%	0.034%
8/21/2026	Pale Fire Capital SE	614,284	$16.57M	0.4%	+68.0%	0.695%
8/20/2026	Montanova Capital LLC	173,886	$4.69M	0.1%	-88.7%	0.197%
8/19/2026	Wellington Management Group LLP	806,716	$21.77M	0.0%	-76.0%	0.912%
8/19/2026	Nantahala Capital Management LLC	820,481	$22.14M	0.0%	N/A	0.928%
Get the Latest News and Ratings for MLYS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
8/17/2026	Capstone Investment Advisors LLC	8,374	$226K	0.0%	N/A	0.009%
8/17/2026	Artia Global Partners LP	137,800	$3.72M	0.7%	N/A	0.156%
8/17/2026	Bank of America Corp DE	1,505,547	$40.62M	0.0%	N/A	1.703%
8/15/2026	Man Group plc	59,640	$1.61M	0.0%	N/A	0.067%
8/15/2026	Jupiter Topco LLC	28,648	$773K	0.0%	N/A	0.032%
8/14/2026	ADAR1 Capital Management LLC	298,886	$8.06M	0.4%	N/A	0.338%
8/14/2026	Canada Pension Plan Investment Board	51,400	$1.39M	0.0%	N/A	0.058%
8/14/2026	Parkman Healthcare Partners LLC	380,354	$10.26M	1.1%	N/A	0.430%
8/14/2026	Legal & General Group Plc	38,050	$1.03M	0.0%	N/A	0.043%
8/14/2026	The Manufacturers Life Insurance Company	32,007	$864K	0.0%	N/A	0.036%
8/14/2026	Algert Global LLC	649,027	$17.51M	0.2%	+149.4%	0.734%
8/12/2026	Greenland Capital Management LP	30,000	$809K	0.1%	N/A	0.036%
8/11/2026	E Fund Management Co. Ltd.	11,025	$297K	0.0%	N/A	0.013%
8/8/2026	Timothy G. Youngquist 2020 Irrevocable Trust	100,869	$2.72M	0.5%	N/A	0.122%
8/7/2026	BlackRock Inc.	5,887,038	$158.83M	0.0%	N/A	7.136%
8/7/2026	Deutsche Bank AG	58,877	$1.59M	0.0%	N/A	0.071%
8/7/2026	TimesSquare Capital Management LLC	235,858	$6.36M	0.1%	N/A	0.286%
8/7/2026	Persistent Asset Partners Ltd	14,410	$389K	0.1%	N/A	0.017%
8/6/2026	Bank of New York Mellon Corp	158,550	$4.28M	0.0%	N/A	0.192%
8/3/2026	Walleye Capital LLC	10,052	$271K	0.0%	N/A	0.012%
7/10/2026	Handelsbanken Fonder AB	27,200	$734K	0.0%	+92.9%	0.033%
7/9/2026	Hennion & Walsh Asset Management Inc.	69,580	$1.88M	0.1%	-0.9%	0.084%
7/8/2026	FNY Investment Advisers LLC	2,500	$67K	0.0%	+400.0%	0.003%
6/4/2026	Seven Fleet Capital Management LP	69,571	$1.89M	0.6%	+65.5%	0.084%
5/19/2026	Bank of America Corp DE	1,100,372	$29.81M	0.0%	+11.5%	1.334%
5/19/2026	Stempoint Capital LP	533,378	$14.45M	2.8%	+83.9%	0.647%
5/19/2026	Janus Henderson Group PLC	19,848	$537K	0.0%	-98.4%	0.024%
5/18/2026	ADAR1 Capital Management LLC	154,686	$4.19M	0.2%	+13.5%	0.187%
5/18/2026	California State Teachers Retirement System	61,266	$1.66M	0.0%	+41.3%	0.074%
5/18/2026	Rock Springs Capital Management LP	439,751	$11.91M	0.7%	+2.8%	0.533%
Elon’s AI Phone is coming (Ad) Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that. See the full evidence behind Elon Musk's rumored new device.
5/16/2026	The Manufacturers Life Insurance Company	26,411	$715K	0.0%	+63.2%	0.032%
5/16/2026	Quantinno Capital Management LP	20,541	$556K	0.0%	+12.6%	0.025%
5/16/2026	Orbimed Advisors LLC	2,052,900	$55.61M	1.0%	+109.4%	2.488%
5/15/2026	Troluce Capital Advisors LLC	655,000	$17.74M	1.1%	N/A	0.794%
5/15/2026	Affinity Asset Advisors LLC	750,000	$20.32M	1.0%	+2.7%	0.909%
5/15/2026	Entropy Technologies LP	10,180	$276K	0.0%	-37.1%	0.012%
5/14/2026	Renaissance Technologies LLC	382,800	$10.37M	0.0%	+18.8%	0.464%
5/14/2026	Pale Fire Capital SE	365,626	$9.91M	0.8%	+3,431.3%	0.443%
5/14/2026	Sei Investments Co.	11,692	$317K	0.0%	+33.2%	0.014%
5/7/2026	KBC Group NV	1,233	$33K	0.0%	N/A	0.001%
5/6/2026	Jennison Associates LLC	1,266,174	$34.30M	0.0%	+0.6%	1.536%
5/5/2026	Bank of New York Mellon Corp	129,964	$3.52M	0.0%	-1.4%	0.158%
5/1/2026	Candriam S.C.A.	801,904	$21.72M	0.1%	+18.2%	0.973%
4/29/2026	Swedbank AB	122,100	$3.31M	0.0%	-44.9%	0.148%
4/27/2026	Y Intercept Hong Kong Ltd	132,099	$3.58M	0.1%	+321.2%	0.160%
4/22/2026	Pictet Asset Management Holding SA	1,034,438	$28.02M	0.0%	+21.3%	1.255%
4/16/2026	SG Americas Securities LLC	225,833	$6.12M	0.0%	-2.1%	0.274%
3/3/2026	Caitong International Asset Management Co. Ltd	3,823	$139K	0.0%	+3,439.8%	0.005%
2/26/2026	Seven Fleet Capital Management LP	15,243	$553K	0.4%	N/A	0.019%
2/19/2026	Invesco Ltd.	29,141	$1.06M	0.0%	-84.5%	0.037%
2/18/2026	XTX Topco Ltd	73,678	$2.67M	0.1%	+291.1%	0.093%
2/18/2026	Zimmer Partners LP	57,500	$2.09M	0.1%	-42.5%	0.073%
2/18/2026	Ikarian Capital LLC	200,000	$7.26M	0.6%	N/A	0.253%
2/18/2026	Virtus Investment Advisers LLC	7,209	$262K	0.1%	-5.5%	0.009%
2/18/2026	Wellington Management Group LLP	784,267	$28.46M	0.0%	+0.1%	0.991%
2/18/2026	Sphera Funds Management LTD.	449,003	$16.29M	3.1%	+104.2%	0.567%
2/18/2026	Suvretta Capital Management LLC	1,538,662	$55.84M	1.1%	-27.8%	1.944%
2/18/2026	Orbimed Advisors LLC	980,400	$35.58M	0.8%	-33.3%	1.239%
2/18/2026	Moore Capital Management LP	60,000	$2.18M	0.0%	-63.6%	0.076%
2/18/2026	Janus Henderson Group PLC	1,213,265	$44.01M	0.0%	+6,012.8%	1.533%
2/18/2026	Findell Capital Management LLC	50,000	$1.81M	0.5%	-80.0%	0.063%
2/18/2026	Catalio Capital Management LP	331,849	$12.04M	2.2%	N/A	0.419%
2/18/2026	Cinctive Capital Management LP	7,037	$255K	0.0%	-90.2%	0.009%
2/18/2026	Artia Global Partners LP	137,800	$5.00M	0.7%	+143.5%	0.174%
2/18/2026	Armistice Capital LLC	676,035	$24.53M	0.3%	+33.2%	0.854%
2/17/2026	ADAR1 Capital Management LLC	136,231	$4.94M	0.4%	+74.1%	0.172%
2/17/2026	Schonfeld Strategic Advisors LLC	49,821	$1.81M	0.0%	+240.8%	0.063%
2/17/2026	AQR Capital Management LLC	62,300	$2.26M	0.0%	+243.8%	0.079%
2/17/2026	Trexquant Investment LP	112,788	$4.09M	0.0%	+156.5%	0.143%
2/17/2026	Laurion Capital Management LP	1,713,485	$62.18M	2.3%	-0.4%	2.165%
2/17/2026	Farallon Capital Management LLC	823,296	$29.88M	0.1%	-50.8%	1.040%
2/17/2026	Iron Triangle Partners LP	257,085	$9.33M	1.1%	N/A	0.325%
2/17/2026	Price T Rowe Associates Inc. MD	1,325,120	$48.09M	0.0%	+6,097.1%	1.674%
2/17/2026	Rock Springs Capital Management LP	427,596	$15.52M	0.8%	+4.7%	0.540%
2/17/2026	California State Teachers Retirement System	43,348	$1.57M	0.0%	+18.4%	0.055%
2/17/2026	Diadema Partners LP	25,000	$907K	0.2%	N/A	0.032%
2/17/2026	Russell Investments Group Ltd.	175,361	$6.36M	0.0%	+5,272.6%	0.222%
2/17/2026	Atom Investors LP	22,330	$810K	0.1%	N/A	0.028%
2/17/2026	State of Wisconsin Investment Board	49,941	$1.81M	0.0%	+85.5%	0.063%
2/17/2026	Royal Bank of Canada	1,529	$56K	0.0%	+262.3%	0.002%
Elon gets it. Do you? (Ad) Moderna's stock jumped nearly 200% in a single day after a successful Phase 3 trial for its cancer drug, and Merck added $43 billion to its market cap on the same news. Porter & Co. says AI-driven drug discovery and automated labs are cutting development timelines by up to 80% and lifting early clinical success rates to 90%, fueling what they call biotech's Ignition Point. Stream the free Ignition Point broadcast for the full biotech breakdown.
2/17/2026	Persistent Asset Partners Ltd	7,416	$269K	0.1%	N/A	0.009%
2/17/2026	Polar Capital Holdings Plc	1,401,141	$50.85M	0.2%	+32.3%	1.770%
2/16/2026	Squarepoint Ops LLC	246,804	$8.96M	0.0%	+473.8%	0.312%
2/16/2026	Mariner LLC	10,230	$371K	0.0%	-37.7%	0.013%
2/16/2026	Maven Securities LTD	20,000	$726K	0.0%	N/A	0.025%
2/16/2026	Entropy Technologies LP	16,175	$587K	0.0%	N/A	0.020%
2/16/2026	Barclays PLC	223,283	$8.10M	0.0%	-65.8%	0.282%
2/13/2026	Nantahala Capital Management LLC	113,285	$4.11M	0.1%	-28.6%	0.143%
2/13/2026	FORA Capital LLC	11,050	$401K	0.0%	+74.7%	0.014%
2/13/2026	Marshall Wace LLP	249,130	$9.04M	0.0%	N/A	0.315%

MLYS Institutional Ownership - Frequently Asked Questions

During the previous two years, 193 institutional investors and hedge funds held shares of Mineralys Therapeutics. The most heavily invested institutionals were Catalys Pacific LLC ($286.83M), RA Capital Management L.P. ($277.72M), BlackRock Inc. ($158.83M), Vanguard Group Inc. ($121.68M), State Street Corp ($115.58M), Caligan Partners LP ($105.14M), and Franklin Resources Inc. ($64.91M).Learn more on Mineralys Therapeutics' institutional investors.

84.46% of Mineralys Therapeutics' stock is owned by institutional investors. Learn more on MLYS's institutional investor holdings.

Of the 176 institutional investors that purchased Mineralys Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($5.89M), Orbimed Advisors LLC ($2.54M), RA Capital Management L.P. ($2.47M), Bank of America Corp DE ($2.25M), Jennison Associates LLC ($2.19M), State Street Corp ($1.90M), and Vanguard Group Inc. ($1.70M).

Institutional investors have bought a total of 39,882,018 shares in the last 24 months. This purchase volume represents approximately $1.34B in transactions.

Of the 57 institutional investors that sold Mineralys Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Wellington Management Group LLP ($2.55M), Capital International Investors ($1.74M), SR One Capital Management LP ($1.56M), Montanova Capital LLC ($1.36M), Integral Health Asset Management LLC ($1.20M), Janus Henderson Group PLC ($1.19M), and Catalys Pacific LLC ($1M).

Institutional investors have sold a total of 16,625,546 shares in the last 24 months. This volume of shares sold represents approximately $561.66M in transactions.

Related Companies

Institutional ownership data for NASDAQ:MLYS is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/9/2026. New 13F filings are added each quarter as they're published.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mineralys Therapeutics (MLYS) Institutional Ownership

MLYS Institutional Buying and Selling by Quarter

Mineralys Therapeutics Major Shareholders & Ownership History

MLYS Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Mineralys Therapeutics (MLYS) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Mineralys Therapeutics (NASDAQ:MLYS)

MLYS Institutional Buying and Selling by Quarter

Mineralys Therapeutics Major Shareholders & Ownership History

MLYS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of MLYS shares?

What percentage of Mineralys Therapeutics' stock is owned by institutional investors?

Which institutional investors have been buying Mineralys Therapeutics' stock?

How much institutional buying is happening at Mineralys Therapeutics?

Which of Mineralys Therapeutics' major shareholders have been selling company stock?

How much institutional selling is happening at Mineralys Therapeutics?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools